Out With the Old In With the New Current Standard of Care NEUTRINO and FISSION SOF RBV pegIFN for Treatmentnaive Patients NEUTRINO and FISSION SOF RBV pegIFN for Treatmentnaive Patients ID: 357018
Download Presentation The PPT/PDF document "Out With the Old and In With the New, Ag..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Out With the Old and In With the New, Again?Slide2
Out With the Old, In With the NewSlide3
Current Standard of CareSlide4
NEUTRINO and FISSION
SOF + RBV ± pegIFN for Treatment-naive PatientsSlide5
NEUTRINO and FISSION
SOF + RBV ± pegIFN for Treatment-naive PatientsSlide6
FUSION
SOF + RBV ± pegIFN in Treatment-experienced Patients With G2,3 HCVSlide7
VALENCESOF + RBV for 12 Weeks or 24 Weeks in G2 or G3 HCV Infection Slide8
QUEST 1 and 2Q80K Variant Adversely Affects SVR12 of SMV-based TherapySlide9
COSMOS
SOF + SIM ± RBV for G1 HCV-infected Patients by Fibrosis StageSlide10
2014
AASLD HCV Treatment GuidelinesSlide11
ION-1On the Road to IFN-free Therapy for G1 HCV InfectionSlide12
ION-3
8 Weeks or 12 Weeks of SOF/LDV for Treatment-naive G1 HCV InfectionSlide13
ION-2SOF/LDV in G1 HCV-infected Patients Failing PegIFN/RBV ± DAASlide14
HALLMARK-DUALPhase 3 Trial of the All-oral Regimen DCV + ASV for G1b HCV InfectionSlide15
SAPPHIRE IABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV for G1 HCV InfectionSlide16
SAPPHIRE IIABT-450/r/Ombitasvir + Dasabuvir + RBV (3D) G1 HCVSlide17
TURQUOISE IIABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV in CirrhosisSlide18
The Past And Future of HCV TherapySlide19
AbbreviationsSlide20
Abbreviations (cont)Slide21
Abbreviations (cont)Slide22
ReferencesSlide23
References (cont)Slide24
References (cont)Slide25
References (cont)